首页> 外文会议>International symposium on bioinformatics research and applications >Inferring Dysregulated Pathways of Driving Cancer Subtypes Through Multi-omics Integration
【24h】

Inferring Dysregulated Pathways of Driving Cancer Subtypes Through Multi-omics Integration

机译:通过多组学整合推断驱动癌症亚型的失调途径

获取原文

摘要

The rapid accumulation of multi-omics cancer data has created the opportunity for biological discovery and biomedical applications. In this study, we propose an approach that integrates multi-omics data to identify dysregulated pathways driving cancer subtypes, which simultaneously considers DNA methylation, DNA copy number, somatic mutation and gene expression profiles. After applying it to Breast Invasive Carcinoma (BRCA) in TCGA, we identify distinct top 30 dysregulated pathways for each breast cancer subtypes. The result suggests that dysregulated pathways of different subtypes display common and specific patterns. Furthermore, 44 differentially expressed genes with corresponding genetic and epigenetic dysregulation are retrieved from the subtype-specific pathways. Literature validation and functional enrichment analysis indicate that these genes are function associated with BRCA. Our method provides a new insight for identifying the driver of cancer subtypes through multi-omics data integration.
机译:多组学癌症数据的快速积累为生物学发现和生物医学应用创造了机会。在这项研究中,我们提出了一种整合多组学数据以识别驱动癌症亚型的失调途径的方法,该方法同时考虑了DNA甲基化,DNA拷贝数,体细胞突变和基因表达谱。在将其应用于TCGA中的乳腺癌浸润癌(BRCA)之后,我们为每种乳腺癌亚型确定了不同的前30个失调通路。结果表明,不同亚型的失调途径显示出共同的和特定的模式。此外,从亚型特异性途径中检索出44个差异表达的基因,其具有相应的遗传和表观遗传失调。文献验证和功能富集分析表明这些基因是与BRCA相关的功能。我们的方法为通过多组学数据集成识别癌症亚型的驱动因素提供了新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号